rs373694973
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002047.4(GARS1):āc.1784T>Cā(p.Val595Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000931 in 1,611,278 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002047.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GARS1 | ENST00000389266.8 | c.1784T>C | p.Val595Ala | missense_variant | Exon 14 of 17 | 1 | NM_002047.4 | ENSP00000373918.3 | ||
GARS1 | ENST00000675651.1 | c.1784T>C | p.Val595Ala | missense_variant | Exon 14 of 17 | ENSP00000502513.1 | ||||
GARS1 | ENST00000675810.1 | c.1682T>C | p.Val561Ala | missense_variant | Exon 13 of 16 | ENSP00000502743.1 | ||||
GARS1 | ENST00000675693.1 | c.1616T>C | p.Val539Ala | missense_variant | Exon 15 of 18 | ENSP00000502174.1 | ||||
GARS1 | ENST00000675051.1 | c.1583T>C | p.Val528Ala | missense_variant | Exon 14 of 17 | ENSP00000502296.1 | ||||
GARS1 | ENST00000674815.1 | c.1415T>C | p.Val472Ala | missense_variant | Exon 14 of 17 | ENSP00000502799.1 | ||||
GARS1 | ENST00000674851.1 | c.1415T>C | p.Val472Ala | missense_variant | Exon 15 of 18 | ENSP00000502451.1 | ||||
GARS1 | ENST00000444666.6 | n.*205T>C | non_coding_transcript_exon_variant | Exon 15 of 18 | 3 | ENSP00000415447.2 | ||||
GARS1 | ENST00000674616.1 | n.*1498T>C | non_coding_transcript_exon_variant | Exon 15 of 18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000674643.1 | n.*884T>C | non_coding_transcript_exon_variant | Exon 15 of 17 | ENSP00000501636.1 | |||||
GARS1 | ENST00000674737.1 | n.*1122T>C | non_coding_transcript_exon_variant | Exon 15 of 18 | ENSP00000502464.1 | |||||
GARS1 | ENST00000674807.1 | n.*57T>C | non_coding_transcript_exon_variant | Exon 13 of 16 | ENSP00000502814.1 | |||||
GARS1 | ENST00000675529.1 | n.*1654T>C | non_coding_transcript_exon_variant | Exon 15 of 18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000675859.1 | n.*57T>C | non_coding_transcript_exon_variant | Exon 13 of 15 | ENSP00000502033.1 | |||||
GARS1 | ENST00000676088.1 | n.*1726T>C | non_coding_transcript_exon_variant | Exon 16 of 19 | ENSP00000501884.1 | |||||
GARS1 | ENST00000676140.1 | n.*729T>C | non_coding_transcript_exon_variant | Exon 14 of 17 | ENSP00000502571.1 | |||||
GARS1 | ENST00000676164.1 | n.*1235T>C | non_coding_transcript_exon_variant | Exon 14 of 17 | ENSP00000501986.1 | |||||
GARS1 | ENST00000676210.1 | n.*1073T>C | non_coding_transcript_exon_variant | Exon 15 of 18 | ENSP00000502373.1 | |||||
GARS1 | ENST00000676259.1 | n.*1216T>C | non_coding_transcript_exon_variant | Exon 14 of 17 | ENSP00000501980.1 | |||||
GARS1 | ENST00000676403.1 | n.1784T>C | non_coding_transcript_exon_variant | Exon 14 of 16 | ENSP00000502681.1 | |||||
GARS1 | ENST00000444666.6 | n.*205T>C | 3_prime_UTR_variant | Exon 15 of 18 | 3 | ENSP00000415447.2 | ||||
GARS1 | ENST00000674616.1 | n.*1498T>C | 3_prime_UTR_variant | Exon 15 of 18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000674643.1 | n.*884T>C | 3_prime_UTR_variant | Exon 15 of 17 | ENSP00000501636.1 | |||||
GARS1 | ENST00000674737.1 | n.*1122T>C | 3_prime_UTR_variant | Exon 15 of 18 | ENSP00000502464.1 | |||||
GARS1 | ENST00000674807.1 | n.*57T>C | 3_prime_UTR_variant | Exon 13 of 16 | ENSP00000502814.1 | |||||
GARS1 | ENST00000675529.1 | n.*1654T>C | 3_prime_UTR_variant | Exon 15 of 18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000675859.1 | n.*57T>C | 3_prime_UTR_variant | Exon 13 of 15 | ENSP00000502033.1 | |||||
GARS1 | ENST00000676088.1 | n.*1726T>C | 3_prime_UTR_variant | Exon 16 of 19 | ENSP00000501884.1 | |||||
GARS1 | ENST00000676140.1 | n.*729T>C | 3_prime_UTR_variant | Exon 14 of 17 | ENSP00000502571.1 | |||||
GARS1 | ENST00000676164.1 | n.*1235T>C | 3_prime_UTR_variant | Exon 14 of 17 | ENSP00000501986.1 | |||||
GARS1 | ENST00000676210.1 | n.*1073T>C | 3_prime_UTR_variant | Exon 15 of 18 | ENSP00000502373.1 | |||||
GARS1 | ENST00000676259.1 | n.*1216T>C | 3_prime_UTR_variant | Exon 14 of 17 | ENSP00000501980.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152244Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 249562Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135398
GnomAD4 exome AF: 0.00000960 AC: 14AN: 1459034Hom.: 0 Cov.: 29 AF XY: 0.0000124 AC XY: 9AN XY: 725946
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152244Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74390
ClinVar
Submissions by phenotype
not provided Uncertain:2
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 25168514, 26503042, 26138142) -
BP4 -
not specified Uncertain:1
The p.V595A variant (also known as c.1784T>C), located in coding exon 14 of the GARS gene, results from a T to C substitution at nucleotide position 1784. The valine at codon 595 is replaced by alanine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Charcot-Marie-Tooth disease type 2 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at